Phathom Pharmaceuticals, Inc. (PHAT)
5.74
-0.48
(-7.72%)
USD |
NASDAQ |
Oct 30, 16:00
5.85
+0.11
(+1.92%)
After-Hours: 20:00
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.1637 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1637 |
| June 30, 2026 | -0.2099 |
| March 31, 2026 | -0.3701 |
| December 31, 2025 | -0.2865 |
| September 30, 2025 | -0.4084 |
| June 30, 2025 | -1.046 |
| March 31, 2025 | -1.310 |
| December 31, 2024 | -1.048 |
| September 30, 2024 | -1.324 |
| June 30, 2024 | -1.562 |
| March 31, 2024 | -1.419 |
| December 31, 2023 | -1.389 |
| September 30, 2023 | -0.7616 |
| June 30, 2023 | -0.8446 |
| March 31, 2023 | -0.8928 |
| December 31, 2022 | -1.332 |
| Date | Value |
|---|---|
| September 30, 2022 | -1.316 |
| June 30, 2022 | -1.330 |
| March 31, 2022 | -1.069 |
| December 31, 2021 | -0.9488 |
| September 30, 2021 | -0.9829 |
| June 30, 2021 | -0.9977 |
| March 31, 2021 | -0.9599 |
| December 31, 2020 | -1.577 |
| September 30, 2020 | -1.022 |
| June 30, 2020 | -0.6395 |
| March 31, 2020 | -0.6203 |
| December 31, 2019 | -3.963 |
| September 30, 2019 | -2.777 |
| December 31, 2018 | -0.0197 |
| September 30, 2018 | -0.0118 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.90M |
| Revenue (Quarterly) | 84.72M |
| Total Expenses (Quarterly) | 98.62M |
| Enterprise Value | 837.11M |
| Gross Profit Margin (Quarterly) | 78.32% |
| Profit Margin (Quarterly) | -16.40% |
| Earnings Yield | -17.95% |
| Normalized Earnings Yield | -17.95 |